Log in or Sign up for Free to view tailored content for your specialty!
Optics News
Uplizna effective in patients with NMOSD previously treated with rituximab
Uplizna appeared to benefit patients with neuromyelitis optica spectrum disorder who were previously treated with rituximab, according to study results published in Multiple Sclerosis and Related Disorders.
Vivid Vision virtual reality technology treats binocular dysfunctions
BOSTON – Vivid Vision software is indicated for treating convergence insufficiency, stereo depth perception, amblyopia and strabismus either in the clinic or at home, according to a presentation here at the American Academy of Optometry meeting.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Wearable technology offers multiple diagnostic tests
BOSTON – The re:Vive from Heru is a wearable, modifiable, gameable, portable visual field system that can be used in a brightly lit room, Mitch Ibach, OD, said here at the American Academy of Optometry meeting.
VIDEO: Orasis completing phase 3 presbyopia drop trial
BOSTON – Orasis Pharmaceuticals anticipates finishing its phase 3 program involving CSF-1 ophthalmic solution for treating presbyopia this year, President and COO Paul Smith said here at the American Academy of Optometry meeting.
Smartphone app may help detect concussions
A smartphone application may help clinicians detect concussion biomarkers, according to study results published in Life.
VIDEO: Presbyopia drop effective in post-LASIK patients
BOSTON – Vuity improves near vision without sacrificing distance vision in patients after LASIK, according to study results presented here at the American Academy of Optometry annual meeting.
VIDEO: Estimates project 300 million to be visually impaired in 2050
BOSTON – Study results presented here at the American Academy of Optometry annual meeting indicate that 300 million people around the world will be visually impaired – classified as 20/40 or worse vision – in 2050.
Heru expands diagnostic tests on wearable platform
BOSTON – Heru announced the release of re:Vive 2.0, which adds color vision, contrast sensitivity and dark adaptation testing to its wearable diagnostic headset.
Vyzulta significantly improves optic nerve blood volume
BOSTON – Treatment with latanoprostene bunod 0.024% induced a significant increase in optic nerve blood volume and oxygen saturation compared with latanoprost 0.005%, according to a presentation at the American Academy of Optometry annual meeting.
VIDEO: Presbyopia drop improves intermediate visual acuity
BOSTON – Vuity, the first eye drop approved for treating presbyopia, showed significant improvement in acuity at intermediate distance at all hours tested through a 10-hour day, according to Chris Lievens, OD, MS, FNAP, FAAO.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read